» Articles » PMID: 17028920

Diagnostic Identification of Malignant Cells in the Cerebrospinal Fluid by Tumor-specific QRT-PCR

Overview
Specialty Oncology
Date 2006 Oct 10
PMID 17028920
Authors
Affiliations
Soon will be listed here.
Abstract

Tumor specific quantitative RT-PCRs for two neuroblastoma specific molecular markers, tyrosine hydroxylase (TH) and GD2 synthase, were used to unequivocally demonstrate the neoplastic nature of the cells present in the cerebrospinal fluid of a neuroblastoma patient. After radical surgery of two separate tumoral lesions, localized in the extradural area, the patient presented with meningitis. Common sites of neuroblastoma metastatization, e.g. bone and bone marrow, were not infiltrated by tumor cells, as assessed by standard scintigraphy, morphological investigation and by sensitive and specific immunocytochemical and molecular assays. The results presented here demonstrate the successful use of tumor-specific qRT-PCRs in cerebrospinal fluid to investigate questionable clinical cases. The technique, which compared to other detection methods (e.g., immunocytochemistry) requires very few cells, yields unambiguous information once a suspected diagnosis has been formulated and a tumor-specific molecular marker is available.

References
1.
Brodeur G, Pritchard J, Berthold F, Carlsen N, Castel V, Castelberry R . Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment. J Clin Oncol. 1993; 11(8):1466-77. DOI: 10.1200/JCO.1993.11.8.1466. View

2.
Peuchmaur M, DAmore E, Joshi V, Hata J, Roald B, Dehner L . Revision of the International Neuroblastoma Pathology Classification: confirmation of favorable and unfavorable prognostic subsets in ganglioneuroblastoma, nodular. Cancer. 2003; 98(10):2274-81. DOI: 10.1002/cncr.11773. View

3.
Matthay K, Brisse H, Couanet D, Couturier J, Benard J, Mosseri V . Central nervous system metastases in neuroblastoma: radiologic, clinical, and biologic features in 23 patients. Cancer. 2003; 98(1):155-65. DOI: 10.1002/cncr.11448. View

4.
Schwab M, Westermann F, Hero B, Berthold F . Neuroblastoma: biology and molecular and chromosomal pathology. Lancet Oncol. 2003; 4(8):472-80. DOI: 10.1016/s1470-2045(03)01166-5. View

5.
Swerts K, Ambros P, Brouzes C, Navarro J, Gross N, Rampling D . Standardization of the immunocytochemical detection of neuroblastoma cells in bone marrow. J Histochem Cytochem. 2005; 53(12):1433-40. PMC: 3957549. DOI: 10.1369/jhc.5C6661.2005. View